***********************************
Brakke Consulting’s
Animal Health News & Notes for February 7, 2025
Copyright © Brakke Consulting
Editor: Lynn Fondon DVM MBA
************************************
IN THE NEWS:
Brakke Consulting News
Cancer in Dogs and Cats report – preorder now
Brakke Consulting 2025 Industry Overview at WVC
Earnings News
Central Garden & Pet
Hill’s
IDEXX
Merck
Phibro
Spectrum Brands
Tyson Foods
Vetoquinol
Other News
Bimeda
Blue Ridge Beef
Ceres Tag
Elanco
Genvax Technologies
Invetx
Logiq
Nona Biosciences
PetDesk
United Animal Health
Vetigenics
Virbac
Zoetis
*****************************************
Brakke Consulting
2025 Cancer in Dogs and Cats report – coming in March
Pre-order by February 28
Did you know that cancer is the #1 cause of death in adult dogs? It’s also a leading health concern of dog owners. So how is cancer addressed by the veterinary profession, and what kind of market is there for veterinary cancer therapies?
Brakke Consulting’s new 2025 Cancer in Dogs and Cats report includes information on the incidence, diagnosis, and treatment of the common veterinary cancers. It covers currently approved veterinary therapies and those in development, as well as estimates of the numbers of pets treated.
The study includes a survey of 300 general veterinary practitioners about incidence of cancer and frequency of treatment; as well as a survey of 1,000 pet owners to determine what they are willing to pay to treat a pet with cancer.
The report is available for pre-order for $7,995 until February 28, and $8,500 thereafter. The report will be published in March. For more information, please contact Dr. Lynn Fondon at info@brakkeconsulting.com .
*********************************************
EARNINGS NEWS RELEASES
- Merck announced financial results for the full year 2024. Animal Health sales were $5,877 million, an increase of 4%. (company press release)
- Vetoquinol reported results for the full year 2024. Annual sales were EUR 539 million ($559 million), a year-over-year increase of 1.9% (up 2.2% at constant exchange rates). US sales were down 6.9% at constant exchange rates. (company website)
- IDEXX Laboratories, Inc. announced results for the full year 2024. Revenue was $3,898 million, a year-over-year increase of 6% as reported and organically. Net income was $888 million, an increase of 5%. Companion Animal Group revenue was $3,574 million, an increase of 7%; segment income from operations was $1,038 million, up 2.5%. (company press release)
- Phibro Animal Health Corporation announced financial results for its second quarter ended December 31, 2024. Net sales were $309 million, an increase of 24%. Net income was $3.2 million, an increase of $1.9 million. Animal Health net sales were $229 million, an increase of 33%, due in part to the Zoetis MFA portfolio acquired on October 31, 2024. (company press release)
- Colgate-Palmolive Company reported results for the full year 2024. Sales for Hill’s Pet Nutrition were $4,483 million, a year-over-year increase of 4%. Segment operating profit was $965 million, an increase of 20%. (company press release)
- Central Garden & Pet Company announced results for its fiscal 2025 first quarter ended December 28, 2024. Net sales for the Pet segment increased 4% to $427 million. (company press release)
- Spectrum Brands Holdings, reported results from continuing operations for the first quarter of fiscal 2025 ended December 29, 2024. Global Pet Care net sales were $260 million, a year-over-year decline of 6%. (company website)
- Tyson Foods reported results for its fiscal 2025 first quarter ended Dec. 28, 2024. Sales were up 2.3% from the prior year to $13.623 billion. Operating income was up 60% to $659 million. (Feedstuffs)
**************************************
Brakke Consulting
Brakke Consulting 2025 Industry Overview
Presented at WVC: Monday, March 3rd , 2-4 pm, Four Seasons Ballroom 4
How did the top animal health companies perform in 2024? What critical issues and new products will impact industry performance in 2025? Answers to these questions and more will be covered at Brakke Consulting’s annual Industry Overview at the VMX and WVC conferences next year. Key topics and presenters include:
- Industry and Top Global Company 2024 Performance, presented by Bob Jones
- Pets and Vets: Companion Animal Practice in Transition, presented by John Volk
- Parasiticides in Pets – Back to the Future, presented by Darrell Klug
- Regenerative Medicine ─ Future Game-Changing Therapies, presented by Mike McGinley
Also, again at both events, you will be able to hear directly from a panel of top leaders in the animal health industry. Moderated by Paul Casady, the topic for the panel will be “Opportunities and Challenges in 2025.” The panelists for WVC are Jesper Nordengaard, CEO, Dechra; and Tammi Lesser, Sr. VP, Sales & Marketing, Antech.
This information-packed 2-hour session will be especially valuable for executive leadership, sales and marketing, strategy, and finance managers and for decision makers in the animal health industry.
Click here to register for WVC
You can also email Amanda McDavid or call at 336-396-3916. Registration cost is $399; there are discounts for multiple attendees from the same company. We look forward to seeing you there!
**************************************
COMPANY NEWS RELEASES
- Zoetis announced that it has updated the U.S. label for Librela, following its submission of a supplement to the FDA. This supplement includes updated labeling based on post-approval experience with Librela in the U.S. since the product launched over a year ago. The updated label and Client Information Sheet will be included in future distributions of Librela. The revised label can be found here. (company press release)
- Elanco Animal Health announced the availability of Pradalex (pradofloxacin injection) for the treatment of bovine respiratory disease (BRD) and swine respiratory disease (SRD). Pradalex is the first new molecule and injectable antibiotic treatment to be approved by the FDA to treat BRD and SRD in roughly two decades. (Feedstuffs)
- Virbac announced it is expanding its US cattle range of products with four vaccines: Bovigen Platinum 5, Bovigen Platinum 5 L5, Bovigen Platinum 3 and Bovigen Platinum 3 LP Vaccines. All four vaccines protect against key respiratory viruses, while BOVIGEN Platinum 5 L5 and 3 LP vaccines add bacterial protection against leptospirosis. (Beef Magazine)
- The FDA announced that Bimeda Animal Health has received approval for Eprimectin Pour-On (generic eprinomectin) for use in Beef and dairy cattle. (FDA)
- Blue Ridge Beef announced a recall of 5,700 lbs. of their 2 lb log Natural Mix due to a contamination of Salmonella. In December, Blue Ridge Beef recalled 9,600 pounds of Puppy Mix sold in seven U.S. states, which was also confirmed as contaminated with Salmonella. (AVMA SmartBrief – com)
- Ceres Tag, an Australian animal health tech company, announced it has selected Overland Park, Kansas, for its first North American headquarters. (company announcement)
- PetDesk announced the upcoming launch of its new AI-powered note-taking solution: PetDesk Scribe, designed to replace the manual note-taking process with reliable transcription intelligence. (com)
- Vetigenics announced the closing of a $6 million seed round. The funds will be used to advance clinical-stage programs toward pivotal trials, accelerate exciting preclinical candidates, and scale up operations and manufacturing. (com)
- Logiq, Inc. announced the launch of AVR BIOVET (aka GrowthMax), a copper-based feed additive designed for enriching and balancing nursing and weaned diets. (com)
- Nona Biosciences announced that it has entered into a strategic collaboration with Invetx, Inc. to develop animal health biotherapeutics using Nona’s HCAb Harbour Mice platform, which generates monoclonal antibodies in both conventional (H2L2) and heavy chain-only (HCAb) formats. (prnewswire)
- Genvax Technologies, a startup dedicated to bringing advances in RNA vaccine production to animal health, announced it has closed its Series Seed Plus funding, accelerating the company’s path toward USDA approval of its vaccines. United Animal Health led the financing with support from Johnsonville Ventures, Iowa Farm Bureau’s Rural Vitality Funds, Iowa Corn Growers Association, and members of Ag Startup Engine. (prweb)
*********************************************
ANIMAL HEALTH STOCK PRICE TRACKER
************************************
BRAKKE CONSULTING VIEWPOINT
As we enter the new year and rush of conferences, product launches, new hires, and more, let’s talk about employer brand. Recruitrics, a major recruitment marketing firm says, “Employer branding became more important than ever this year as competition for top talent intensified.”
As we shift from Baby Boomers to Gen Z, we should shift our priorities and messaging. Beyond compensation, Gen Zs value meaningful work and a supportive culture. “65% … won’t apply for a job if the employer’s values aren’t aligned with theirs.”
Authenticity is the new watchword. With the omnipresence of digital communications, personalized authenticity wins the day.
How to address this megatrend? “Regularly update your company’s social media, career site, and other platforms with stories about your employees, workplace diversity, and community engagement … Present a well-rounded, appealing picture of your organization that will resonate with your target talent.” Focus on employees’ feelings and experiences, stressing well-being and mental health. Use video liberally, particularly in team member testimonials. Where possible personalize messages, aligning your culture with candidates’ backgrounds. With a definitive mission for animal health, our industry enjoys an enviable position. Leverage it.
Remember, we’re selling more than buying! Brakke Consulting can help.
Jeff Santosuosso
***********************************
YOUR VIEW
Last week, we asked how much time you think it takes for the majority of veterinarians to become comfortable prescribing and using novel classes of veterinary drugs. Most of you (64%) said it takes 2 or 3 years; another 26% said it takes a year or less, and 10% said 4 or 5 years. No one thought it takes more than 5 years.
This week
What is your company’s current and near-term position on employer branding?
English (United States) 
Portuguese